355 related articles for article (PubMed ID: 33168626)
1. The 89-kDa PARP1 cleavage fragment serves as a cytoplasmic PAR carrier to induce AIF-mediated apoptosis.
Mashimo M; Onishi M; Uno A; Tanimichi A; Nobeyama A; Mori M; Yamada S; Negi S; Bu X; Kato J; Moss J; Sanada N; Kizu R; Fujii T
J Biol Chem; 2021; 296():100046. PubMed ID: 33168626
[TBL] [Abstract][Full Text] [Related]
2. PARP1 inhibition alleviates injury in ARH3-deficient mice and human cells.
Mashimo M; Bu X; Aoyama K; Kato J; Ishiwata-Endo H; Stevens LA; Kasamatsu A; Wolfe LA; Toro C; Adams D; Markello T; Gahl WA; Moss J
JCI Insight; 2019 Feb; 4(4):. PubMed ID: 30830864
[TBL] [Abstract][Full Text] [Related]
3. ADP-ribosyl-acceptor hydrolase 3 regulates poly (ADP-ribose) degradation and cell death during oxidative stress.
Mashimo M; Kato J; Moss J
Proc Natl Acad Sci U S A; 2013 Nov; 110(47):18964-9. PubMed ID: 24191052
[TBL] [Abstract][Full Text] [Related]
4. PARP1 inhibition prevents oxidative stress in age-related hearing loss via PAR-Ca
Wan H; Chen H; Liu J; Yang B; Zhang Y; Bai Y; Chen X; Wang J; Liu T; Zhang Y; Hua Q
Free Radic Biol Med; 2024 Aug; 220():222-235. PubMed ID: 38735540
[TBL] [Abstract][Full Text] [Related]
5. Poly(ADP-ribose) Polymerase 1 Mediates Rab5 Inactivation after DNA Damage.
Mashimo M; Morozumi A; Nobeyama A; Kanzaki M; Negi S; Kato J; Moss J; Nomura A; Fujii T
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887176
[TBL] [Abstract][Full Text] [Related]
6. Regulation of Poly(ADP-Ribose) Polymerase 1 Activity by Y-Box-Binding Protein 1.
Naumenko KN; Sukhanova MV; Hamon L; Kurgina TA; Alemasova EE; Kutuzov MM; Pastré D; Lavrik OI
Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32947956
[TBL] [Abstract][Full Text] [Related]
7. Poly(ADP-ribose) (PAR) binding to apoptosis-inducing factor is critical for PAR polymerase-1-dependent cell death (parthanatos).
Wang Y; Kim NS; Haince JF; Kang HC; David KK; Andrabi SA; Poirier GG; Dawson VL; Dawson TM
Sci Signal; 2011 Apr; 4(167):ra20. PubMed ID: 21467298
[TBL] [Abstract][Full Text] [Related]
8. Activation of cell death mediated by apoptosis-inducing factor due to the absence of poly(ADP-ribose) glycohydrolase.
Zhou Y; Feng X; Koh DW
Biochemistry; 2011 Apr; 50(14):2850-9. PubMed ID: 21366272
[TBL] [Abstract][Full Text] [Related]
9. Poly(ADP-ribose) signals to mitochondrial AIF: a key event in parthanatos.
Wang Y; Dawson VL; Dawson TM
Exp Neurol; 2009 Aug; 218(2):193-202. PubMed ID: 19332058
[TBL] [Abstract][Full Text] [Related]
10. Arsenite-induced cytotoxicity is regulated by poly-ADP ribose polymerase 1 activation and parthanatos in p53-deficient H1299 cells: The roles of autophagy and p53.
So KY; Oh SH
Biochem Biophys Res Commun; 2023 May; 656():78-85. PubMed ID: 36958258
[TBL] [Abstract][Full Text] [Related]
11. PARP1 is activated by membrane damage and is involved in membrane repair through poly(ADP-ribosyl)ation.
Mashimo M; Kita M; Nobeyama A; Nomura A; Fujii T
Genes Cells; 2022 Apr; 27(4):305-312. PubMed ID: 35124853
[TBL] [Abstract][Full Text] [Related]
12. Sex differences in the response to activation of the poly (ADP-ribose) polymerase pathway after experimental stroke.
Yuan M; Siegel C; Zeng Z; Li J; Liu F; McCullough LD
Exp Neurol; 2009 May; 217(1):210-8. PubMed ID: 19268668
[TBL] [Abstract][Full Text] [Related]
13. The poly(ADP-ribosyl)ation of FoxO3 mediated by PARP1 participates in isoproterenol-induced cardiac hypertrophy.
Lu J; Zhang R; Hong H; Yang Z; Sun D; Sun S; Guo X; Ye J; Li Z; Liu P
Biochim Biophys Acta; 2016 Dec; 1863(12):3027-3039. PubMed ID: 27686254
[TBL] [Abstract][Full Text] [Related]
14. Regulatory apoptotic fragment of PARP1 complements catalytic fragment for PAR and DNA-dependent activity but inhibits DNA-induced catalytic stimulation of PARP2.
Deeksha W; Rajakumara E
DNA Repair (Amst); 2024 Jan; 133():103593. PubMed ID: 38029688
[TBL] [Abstract][Full Text] [Related]
15. LPS protects macrophages from AIF-independent parthanatos by downregulation of PARP1 expression, induction of SOD2 expression, and a metabolic shift to aerobic glycolysis.
Regdon Z; Robaszkiewicz A; Kovács K; Rygielska Ż; Hegedűs C; Bodoor K; Szabó É; Virág L
Free Radic Biol Med; 2019 Feb; 131():184-196. PubMed ID: 30502458
[TBL] [Abstract][Full Text] [Related]
16. The key players of parthanatos: opportunities for targeting multiple levels in the therapy of parthanatos-based pathogenesis.
Liu L; Li J; Ke Y; Zeng X; Gao J; Ba X; Wang R
Cell Mol Life Sci; 2022 Jan; 79(1):60. PubMed ID: 35000037
[TBL] [Abstract][Full Text] [Related]
17. Poly(ADP-ribosyl)ation by PARP1: reaction mechanism and regulatory proteins.
Alemasova EE; Lavrik OI
Nucleic Acids Res; 2019 May; 47(8):3811-3827. PubMed ID: 30799503
[TBL] [Abstract][Full Text] [Related]
18. Replication protein A as a modulator of the poly(ADP-ribose)polymerase 1 activity.
Maltseva EA; Krasikova YS; Sukhanova MV; Rechkunova NI; Lavrik OI
DNA Repair (Amst); 2018 Dec; 72():28-38. PubMed ID: 30291044
[TBL] [Abstract][Full Text] [Related]
19. Poly (ADP-ribose) in the pathogenesis of Parkinson's disease.
Lee Y; Kang HC; Lee BD; Lee YI; Kim YP; Shin JH
BMB Rep; 2014 Aug; 47(8):424-32. PubMed ID: 24874851
[TBL] [Abstract][Full Text] [Related]
20. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.
Henning RJ; Bourgeois M; Harbison RD
Cardiovasc Toxicol; 2018 Dec; 18(6):493-506. PubMed ID: 29968072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
